LYMPHOCYTE SUBSETS AND HLA-DR EXPRESSION IN NORMAL PANCREAS AND CHRONIC-PANCREATITIS

被引:50
作者
BEDOSSA, P
BACCI, J
LEMAIGRE, G
MARTIN, E
机构
[1] Laboratoire d'Anatomie Pathologique, Hôpital Antoine Béclère, Clamart
[2] Hôpital de Bicêtre, Le Kremlin-Bicêtre
关键词
Chronic pancreatitis; Immunohistochemistry; Lymphocytes; Major histocompatibility complex; Pancreas;
D O I
10.1097/00006676-199007000-00007
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
In an attempt to study the mechanisms leading to fibrosis in chronic pancreatitis, an in situ immunohistochemical investigation of lymphocytes and of class II major histocompatibility complex expression (HLA-DR) by epithelial cells has been designed. Samples of normal pancreas (n = 8), chronic calcifying pancreatitis (n = 4), chronic obstructive pancreatitis in = 6), and diffuse fibrosing pancreatitis (n = 6) have been studied. In normal pancreas, T-lymphocytes were rare and were located in the epithelial layer of pancreatic ducts and in the periductal connective tissue. Duct cells were constantly HLA-DR negative. In chronic calcifying pancreatitis and chronic obstructive pancreatitis, T cells were numerous and were located around ducts and in the spreading areas of fibrous septa. In chronic obstructive pancreatitis, the duct cells strongly expressed the HLA-DR antigen. In diffuse fibrosing pancreatitis, fibrous tissue was devoid of lymphocytes and duct cells never expressed the HLA class II antigen. These results suggest that lymphocytes are involved in the fibrosing process occurring in chronic calcifying pancreatitis and chronic obstructive pancreatitis but not in diffuse fibrosing pancreatitis. The significance of de novo expression of HLA-DR antigen by duct cells is discussed. © 1990 Raven Press Ltd., New York.
引用
收藏
页码:415 / 420
页数:6
相关论文
共 30 条
[1]  
Dani R., Antunes L.J., Ribeiro J., Nogueira C., Ribeiro T., Immunological participation in chronic calcifying pancreatitis, Digestion, 11, pp. 333-337, (1974)
[2]  
Bank S., Novis B.H., Petersen E., Dowdle E., Marks I.N., Serum immunoglobulins in calcifying pancreatitis, Gut, 14, pp. 723-725, (1973)
[3]  
Clemente F., Ribeiro T., Colombe E., Figarella C., Sarles H., Comparaison des protéines de sue pancréatiques humains normaux et pathologiques. Dosage des protéines sériques et mise en évidence d'une protéine particuliére dans la pancréatite chronique calcifiante, Biochem Biophys Acta, 251, pp. 456-466, (1971)
[4]  
Fonkalsrud E.W., Longemire W.P., The occurrence of pancreatic antibodies and the experimental production of pancreatitis with pancreatic antiserum, Surgery, 50, pp. 134-142, (1961)
[5]  
Thai A.P., Murray M.J., Egner W., Isoantibody formation in chronic pancreatic disease, Lancet, 1, pp. 1128-1129, (1959)
[6]  
Wybran J., Fudenberg H.H., Thymus derived rosette-forming cells in various human disease states: Cancer, lymphoma, bacterial and viral infections and other diseases?, J Clin Invest, 52, pp. 1026-1032, (1973)
[7]  
Schiff C., Friemil H., Schulze H.A., Zubaidi G., Specific lymphocyte sensitization in chronic pancreatitis, Digestion, 13, pp. 308-311, (1975)
[8]  
Kanagasundaram N., Levy C.M., Ethanol, immune reactions and the digestive system, Clin Gastroenterol, 10, pp. 295-302, (1981)
[9]  
Gyr K., Singer M.V., Sarles H., Pancreatitis: Concepts and Classification, (1984)
[10]  
Martin E., Bedossa P., Diffuse fibrosis of the pancreas